Cancer Immunotherapy Spurs Work on Better Animal Models
GEN Spoke to Several Researchers on Advances in Engineered Animal Models Used to Study Novel Cancer Im-munotherapies
The Rise of Single-Cell Genomics
The Ability to Profile Single Whole Cells and Single Nuclei Will Also Help Shape Understanding of Each Cell Type
Philadelphia Project Gains STEAM
Artists Partner with Biotech to Inspire Young Scientists
Copy Number Variation Probes Inform Diverse Applications
Better Methods to Analyze and Organize DNA Fragments Are Emerging
For full access to this article login to GEN Select now.
Advancing Cancer Vaccines
A Drug Class Almost Ready to Take Off
- The cadre of speakers extolling the virtues of therapeutic cancer vaccines at the recent “World Vaccine Congress” in Lyon, France, included Vincent Brichard, M.D., Ph.D., vp, cancer immunotherapeutics, GlaxoSmithKline Biologicals (www.gsk-bio.com). “Many would say that therapeutic cancer vaccines have experienced 20 years of failure, but I would say it ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.